4qum Citations

Reciprocal allosteric regulation of p38γ and PTPN3 involves a PDZ domain-modulated complex formation.

Sci Signal 7 ra98 (2014)
Cited: 16 times
EuropePMC logo PMID: 25314968

Abstract

The mitogen-activated protein kinase p38γ (also known as MAPK12) and its specific phosphatase PTPN3 (also known as PTPH1) cooperate to promote Ras-induced oncogenesis. We determined the architecture of the PTPN3-p38γ complex by a hybrid method combining x-ray crystallography, small-angle x-ray scattering, and chemical cross-linking coupled to mass spectrometry. A unique feature of the glutamic acid-containing loop (E-loop) of the phosphatase domain defined the substrate specificity of PTPN3 toward fully activated p38γ. The solution structure revealed the formation of an active-state complex between p38γ and the phosphatase domain of PTPN3. The PDZ domain of PTPN3 stabilized the active-state complex through an interaction with the PDZ-binding motif of p38γ. This interaction alleviated autoinhibition of PTPN3, enabling efficient tyrosine dephosphorylation of p38γ. Our findings may enable structure-based drug design targeting the PTPN3-p38γ interaction as an anticancer therapeutic.

Articles - 4qum mentioned but not cited (4)

  1. Community-Wide Experimental Evaluation of the PROSS Stability-Design Method. Peleg Y, Vincentelli R, Collins BM, Chen KE, Livingstone EK, Weeratunga S, Weeratunga S, Leneva N, Guo Q, Remans K, Perez K, Bjerga GEK, Larsen Ø, Vaněk O, Skořepa O, Jacquemin S, Poterszman A, Kjær S, Christodoulou E, Albeck S, Dym O, Ainbinder E, Unger T, Schuetz A, Matthes S, Bader M, de Marco A, Storici P, Semrau MS, Stolt-Bergner P, Aigner C, Suppmann S, Goldenzweig A, Fleishman SJ. J Mol Biol 433 166964 (2021)
  2. Network Pharmacology-Based Approach to Investigate the Molecular Targets of Sinomenine for Treating Breast Cancer. Li XM, Li MT, Jiang N, Si YC, Zhu MM, Wu QY, Shi DC, Shi H, Luo Q, Yu B. Cancer Manag Res 13 1189-1204 (2021)
  3. Structural insights into the pSer/pThr dependent regulation of the SHP2 tyrosine phosphatase in insulin and CD28 signaling. Zeke A, Takács T, Sok P, Németh K, Kirsch K, Egri P, Póti ÁL, Bento I, Tusnády GE, Reményi A. Nat Commun 13 5439 (2022)
  4. Mahuang Fuzi Xixin decoction: A potent analgesic for neuropathic pain targeting the NMDAR2B/CaMKIIα/ERK/CREB pathway. Chai Y, He S, Liang D, Gu C, Gong Q, Long L, Chen P, Wang L. Heliyon 10 e35970 (2024)


Reviews citing this publication (4)

  1. p38γ and p38δ Mitogen Activated Protein Kinases (MAPKs), New Stars in the MAPK Galaxy. Escós A, Risco A, Alsina-Beauchamp D, Cuenda A. Front Cell Dev Biol 4 31 (2016)
  2. Genetic profiling of intrahepatic cholangiocarcinoma and its clinical implication in targeted therapy. Xie D, Ren Z, Fan J, Gao Q. Am J Cancer Res 6 577-586 (2016)
  3. Targeting an oncogenic kinase/phosphatase signaling network for cancer therapy. Qi XM, Wang F, Mortensen M, Wertz R, Chen G. Acta Pharm Sin B 8 511-517 (2018)
  4. p38γ MAPK Inflammatory and Metabolic Signaling in Physiology and Disease. Qi XM, Chen G. Cells 12 1674 (2023)

Articles citing this publication (8)